(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






Latest News Releases From The Newsroom

Amaya Provides Update on Rational Group Deferred Payment

January 09th, 2017

Montreal, Canada / CRWE PRESS RELEASE / January 9, 2017 - Amaya Inc. (Nasdaq: AYA; TSX: AYA) today announced its financing plan for the approximately $197.7 million balance of the deferred purchase price for its acquisition of the Rational . Read more

Puma Biotechnology Expands Cohort in Phase II SUMMIT Trial of PB272 in HER2 Mutation-Positive Cancer Patients

January 06th, 2017

LOS ANGELES, Calif. / CRWE PRESS RELEASE / Jan. 6, 2017 - Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, has expanded the fourth cohort from its Phase II SUMMIT clinical trial of its lead drug candidate PB272 (neratinib) as a s. Read more

Tahoe Resources Achieves Record Silver And Gold Production In 2016, Announces 2017 Financial And Operating Guidance

January 05th, 2017

VANCOUVER, British Columbia / CRWE PRESS RELEASE / January 5, 2017 - Tahoe Resources Inc. (“Tahoe” or the “Company”) (TSX: THO; NYSE: TAHO) today reported record silver and gold production in 2016 and announced the Company&rsq. Read more

BlackBerry and Giuliani Partners Join Forces to Combat Cyber Threats

January 05th, 2017

LAS VEGAS, NEVADA / CRWE PRESS RELEASE / Jan. 5, 2017 - International CES 2017 - BlackBerry Limited (NASDAQ:BBRY)(TSX:BB) today announced that BlackBerry Secure has been selected by Giuliani Partners as the underlying software platform to support the. Read more

BlackBerry QNX Launches its Most Advanced and Secure Embedded Software Platform for Autonomous Drive and Connected Cars

January 04th, 2017

LAS VEGAS, NEVADA / CRWE PRESS RELEASE / Jan. 4, 2017 - International CES 2017, LVCC North Hall, Booth 7029 - BlackBerry Limited (NASDAQ:BBRY) (TSX:BB) today announced its most advanced and secure embedded operating system (OS) for the automotive ind. Read more

Ritter Pharmaceuticals Phase 2a Lactose Intolerance Clinical Trial Microbiome Data, Published in Proceedings of the National Academy of Science

January 03rd, 2017

LOS ANGELES, CA / CRWE PRESS RELEASE / January 3, 2017 - Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the human gut micro. Read more

Bombardier and Austrian Federal Railways Sign Framework Agreement for up to 300 TALENT 3 Trains

December 29th, 2016

* First call-off for 21 new BOMBARDIER TALENT 3 regional trains * New trains offer increased accessibility, bicycle storage, state-of-the art passenger information system and higher passenger capacity Berlin, Germany / CRWE PRESS RELEASE / Decemb. Read more

Pluristem and New York Blood Center to Collaborate in Evaluating PLX-R18 as an Adjuvant Therapy to Umbilical Cord Blood Transplantation, Winning $900,000 Funding From BIRD

December 27th, 2016

* Prior research has suggested that PLX-R18 helps cord blood cells to engraft more rapidly and effectively * Grant of $900,000 from Israel-U.S. Binational Industrial Research and Development Foundation (BIRD) to fund the research * Constitutes a 3r. Read more

Mechel Has Completed Restructuring with Russian State Banks

December 26th, 2016

Moscow, Russia / CRWE PRESS RELEASE / December 26, 2016 – Mechel PAO (MICEX: MTLR, NYSE: MTL), one of the leading Russian mining and metals companies, reports signing agreements with VTB Bank for extending the maturity of the debt on . Read more

Ballard Reports Progress on Stack Production Capability in China

December 23rd, 2016

* Ballard has received $19.0M in related payments VANCOUVER, CANADA and YUNFU, CHINA / CRWE PRESS RELEASE / December 22, 2016 - Ballard Power Systems (NASDAQ: BLDP; TSX: BLD) today has provided an update regarding significant progress being made t. Read more